A neurologist by training, Stefánsson founded Iceland-based deCODE Genetics to explore what the human genome can tell us about disease and our species’ evolution.

The PsychENCODE project delves into the DNA, RNA, and protein changes related to brain development and neuropsychiatric disorders, but researchers caution it’s just a first step toward treatment.

Complications during pregnancy may act via the placenta to magnify the effects of genetic risk factors.

The neuronal coverings that mediate synaptic changes are involved in everything from memory to psychiatric disorders, affecting autism, Alzheimer’s, and addiction.

See the web of proteins that make up these neuronal wrappings.

Transcriptional profiling of post-mortem human brains reveals commonalities in the genes over- and under-expressed in schizophrenia, bipolar disorder, autism, and major depression. 

Scientists are beginning to unravel the mechanisms behind the therapeutic effects of psychedelic drugs.

Mice lacking the RNA had deregulated microRNAs in the brain, disrupted synaptic communication, and behavioral abnormalities associated with neuropsychiatric disorders.

Genetic variants on chromosome 26 appears to play a role in a dog’s tendency to turn to people for help.